CT scans performed more than five years after a lung cancer diagnosis reduce all-cause mortality among long-term survivors, according to a study published November 19 in JAMA Oncology.
A group from Samsung Medical Center in Seoul, South Korea, evaluated CT surveillance in patients who survived at least five years after lung cancer diagnosis, with findings suggesting continued scanning is associated with improved survival, noted lead authors Dong Woog Yoon, MD, PhD, and Danbee Kang, PhD, and colleagues.
"CT receipt beyond 5 years after diagnosis was associated with increased [lung cancer] detection, greater use of surgical resection after [lung cancer] detection, and a lower all-cause mortality rate," the researchers noted. " These associations were particularly pronounced among older adults, females, and never smokers."
Current guidelines recommend periodic chest CT after lung cancer treatment but do not specify how long surveillance should be continued or when it can be safely discontinued, the group explained. Long-term survivors remain at risk of lung cancer events (LCEs), including late recurrence and second primary lung cancer, beyond the five-year mark, yet evidence supporting extended surveillance is limited, they added.
To bridge the gap, the researchers analyzed Korean National Health Insurance Service data on 55,694 lung cancer survivors diagnosed between 2006 to 2019. During a median follow-up of 2.74 (1.16-5.18) years, CT receipt was associated with a higher incidence of LCEs (2.49% versus 1.97% per year; hazard ratio [HR], 1.28) and lower all-cause mortality rate (2.62% versus 4.33% per year; HR, 0.66) compared with no CT receipt, the researchers reported.
In addition, among patients who experienced an LCE, those in the CT group were more likely to undergo surgical resection (odds ratio, 1.46). Lastly, the associations were observed more frequently among females (HR, 0.47), older adults (HR, 0.57), and never smokers (HR, 0.55), the researchers noted.
"The higher likelihood of surgical resection and lower mortality rate among patients undergoing surveillance suggest that some detected LCEs represented clinically meaningful treatment opportunities," the group wrote.
Because uniform annual CT surveillance for all long-term lung cancer survivors would increase imaging use, downstream evaluations, and health care costs, risk-adapted surveillance strategies warrant further evaluation, the researchers concluded.
The full study is available here.
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.